Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

瑞度 - NMPA Drug Approval Details

Approvals/NMPA/Indocyanine Green for Injection

Approved

化学药品

Indocyanine Green for Injection

丹东医创药业有限责任公司;杭州澳亚生物技术股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Jun 19, 2020
Approval ID: 7LeaeIE1xDX
Company: 丹东医创药业有限责任公司;杭州澳亚生物技术股份有限公司
Type: 化学药品

Approval Details

Approval Id: 7LeaeIE1xDX
Approval Number: 国药准字H20055881
Generic Name: 注射用吲哚菁绿
Generic Name En: Indocyanine Green for Injection
Brand Name: 瑞度
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 25mg
Reg Date: 2020-06-19
Company Name: 丹东医创药业有限责任公司;杭州澳亚生物技术股份有限公司
Production Company Name: 丹东医创药业有限责任公司;杭州澳亚生物技术股份有限公司
Production Company Address: 辽宁省丹东市东港市永祥街6号；杭州经济技术开发区一号大街1号

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jun 19, 2020

Approval ID

7LeaeIE1xDX

Type

化学药品

Back to NMPA Approvals